This Article Full Text Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kurashina, T. Articles by Kirchner, K. A. Search for Related Content PubMed PubMed Citation Articles by Kurashina, T. Articles by Kirchner, K. A.

(Hypertension. 1997;30:660.)
© 1997 American Heart Association, Inc.

Articles

Pressure Natriuresis After Adrenomedullin in Anesthetized Spontaneously Hypertensive Rats

Toshiaki Kurashina; Ami R. Patel; Joey P. Granger; Kent A. Kirchner

From the Medical Service, Department of Veterans Affairs Medical Center, and the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson.

Correspondence to K.A. Kirchner, MD, Medical Service, G.V. (Sonny) Montgomery Department of Veterans Affairs Medical Center, 1500 E. Woodrow Wilson Dr, Jackson, MS 39216.

Abstract Adrenomedullin (ADM), a peptide with potent vasodilatory and natriuretic actions, is elevated in patients with essential hypertension. Because pharmacological doses of ADM result in renal vasodilation and natriuresis, it has been suggested that ADM may play a modulatory role in hypertension through potential actions on renal pressure natriuresis. However, it is unclear whether elevation of plasma ADM within the pathophysiological range has similar actions. To determine the effects of pathophysiological doses of ADM on blood pressure and on the relationship between renal perfusion pressure (RPP) and renal hemodynamics and sodium excretion, renal function was determined at RPPs of 80, 105, 130, and 155 mm Hg in spontaneously hypertensive rats (SHR) infused with ADM at 50 ng · kg^-1 · min^-1 (ADM-50, n=5) and at 100 ng · kg^-1 · min^-1 (ADM-100, n=5) and in control SHR (n=5). Decreasing RPP from 155 to 80 mm Hg in control SHR decreased (P<.05) absolute sodium excretion from 0.81±0.25 to 0.04±0.02 µEq/min, fractional sodium excretion from 0.32±0.11% to 0.06±0.04%, and urine flow rate from 11.5±2.8 to 1.03±0.31 µL/min. ADM infusion elevated (P<.05) plasma ADM levels in ADM-infused SHR (679±47 pg/mL in ADM-50, 858±79 in ADM-100) compared with control (79.5±27.8). However, although reduction of RPP from 155 to 80 mm Hg in ADM rats decreased absolute sodium excretion (ADM-50, 0.98±0.10 to 0.09±0.04 µEq/min; ADM-100, 0.95±0.09 to 0.07±0.02 µEq/min), fractional sodium excretion (ADM-50, 0.31±0.03% to 0.17±0.04%; ADM-100, 0.33±0.02% to 0.09±0.01%), and urine flow (ADM-50, 13.6±1.4 to 1.73±0.75 µL/min; ADM-100, 13.5±1.5 to 1.07±0.16 µL/min), these decreases were not different from values found in controls. Renal plasma flow and glomerular filtration rate were also similar in control and ADM-treated SHR at each level of RPP. Thus, acute increases in ADM to levels found in pathophysiological conditions have no effect on blood pressure, pressure natriuresis, or renal autoregulation in the SHR. These findings do not support the hypothesis that ADM serves as a modulating factor in hypertension, at least in the SHR.

Key Words: adrenomedullin • hypertension • pressure natriuresis

This article has been cited by other articles:

				K.-H. Hofbauer, B. L. Jensen, A. Kurtz, and P. Sandner Tissue hypoxygenation activates the adrenomedullin system in vivo Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2000; 278(2): R513 - R519. [Abstract] [Full Text] [PDF]